Thursday, March 10, 2022 8:12:46 AM
CARSON CITY, Nev., March 10, 2022 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today announced that an interview with President and CEO Cuong Do will air on The RedChip Money Report(TM) on Bloomberg TV, March 12, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the United States.
The RedChip Money Report(TM) is produced by RedChip Companies Inc., an international Investor Relations and media firm with 30 years' experience focused on Discovering Tomorrow's Blue Chips Today(TM). "The RedChip Money Report(TM)" delivers insightful commentary on small cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.
To view the interview segment, please visit:
The RedChip Money Report(TM) is produced by RedChip Companies Inc., an international Investor Relations and media firm with 30 years' experience focused on Discovering Tomorrow's Blue Chips Today(TM). "The RedChip Money Report(TM)" delivers insightful commentary on small cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.
To view the interview segment, please visit:
History.htm
Recent BIVI News
- Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV • ACCESS Newswire • 10/17/2025 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/15/2025 09:05:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2025 08:25:18 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/08/2025 09:09:59 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/08/2025 04:15:18 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/04/2025 12:52:40 PM
- Biovie shares climb as Alzheimer’s drug shows promising age deceleration effects • IH Market News • 07/24/2025 03:10:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2025 08:49:55 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/22/2025 12:31:37 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/11/2025 09:19:50 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/03/2025 09:01:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/27/2025 09:20:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/24/2025 09:20:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/02/2025 08:16:06 PM
